Browsing by Author Chua, Wei

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)Citation
2015Biomarkers in Metastatic Colorectal CancerCharles (nee Slaviero), Kellie Anne; Clarke, Stephen; Diakos, Connie; Howell, Viive; Chua, Wei; School of Medical Sciences: Pharmacology; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteBiomarkers in Metastatic Colorectal Cancer in Biomarkers in Cancer, Springer, 2015, pp. 601-630
2011Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancerCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Kho, Patricia; Moore, Melissa; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: MedicineClinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer, Critical Reviews in Oncology / Hematology, vol.79, 3, 2011,pp 224-250
2014Effect of neoadjuvant chemoradiation on tumor infiltrating/associated lymphocytes in locally advanced rectal cancersLee, Cheok; Solomon, Michael; Bokey, Les; Cheng, Christine; Chua, Wei; De Souza, Paul; Descallar, Joseph; Lee, Mark; Lim, Stephanie Hui-Su; Ng, Weng; Shin, Joo-Shik; Wong, Karen; Central Clinical School: Medicine; Central Clinical School: SurgeryEffect of neoadjuvant chemoradiation on tumor infiltrating/associated lymphocytes in locally advanced rectal cancers, Anticancer Research: international journal of cancer research and treatment, vol.34, 11, 2014,pp 6505-6514
2010Inflammation and Cancer: Causes and ConsequencesCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Moore, M; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; MedicineInflammation and Cancer: Causes and Consequences, Clinical Pharmacology and Therapeutics, vol.87, 4,pp 504-508
2010Is it Prime Time for Personalized Medicine in Cancer Treatment?Chua, Wei; Clarke, Stephen; Kho, Patricia; Moore, Melissa; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: MedicineIs it Prime Time for Personalized Medicine in Cancer Treatment?, Personalized Medicine, vol.7, 4,pp 387-397
2009Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancerChua, Wei; Dhillon, Haryana; Clark, SJ.; Goldstein, D; Iacopetta, Barry J.; Lee, CK.; Michael, Michael; Mitchell, Paul L.; Concord Clinical School: Medicine; Central Clinical School: MedicineMolecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer, British Journal of Cancer, vol.101, 6,pp 998-1004
2011Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Baracos, V E; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer, British Journal of Cancer, vol.104, 8, 2011,pp 1288-1295
2016The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor TherapyToh, James; Chua, Wei; de Souza, Paul; Lim, Stephanie; Ng, Weng; Singh, Puneet; Spring, Kevin; Central Clinical School: MedicineThe Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy, Clinical Colorectal Cancer, vol.15, 4, 2016,pp 285-291
2015Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancerLee, Cheok; Asghari, R; Chantrill, Lorraine; Chua, Wei; de Souza, P; Henderson, C; Lim, Stephanie; Ng, Weng; Shin, J; Spring, K; Central Clinical School: MedicinePredictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer, Critical Reviews in Oncology / Hematology, vol.96, 1, 2015,pp 67-80
2015Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspectiveYip, Po Yee; Becker, T; Bray, Victoria J.; Caixeiro, N; Chua, Wei; de Souza, P; Lim, Stephanie; Spring, K; Tognela, A; MedicinePredictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective, Critical Reviews in Oncology / Hematology, vol.93, 2, 2015,pp 90-102
2009Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer.Charles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Moore, Melissa; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstitutePredictive biomarkers of clinical response to targeted antibodies in colorectal cancer., Current Opinion in Molecular Therapeutics, vol.11, 6,pp 611-622
2012Reporting clinical trial information: colorectal cancer trials at Sydney Cancer CentreBeale, Philip; Chua, Wei; Clarke, Stephen; Horvath, L G; Central Clinical School: Medicine; Concord Clinical School: Medicine; Northern Clinical School: Kolling InstituteReporting clinical trial information: colorectal cancer trials at Sydney Cancer Centre, Internal Medicine Journal, vol.42, 4, 2012,pp 416-421
2008Retrospective review of mitomycin C use as third-line chemotherapy in metastatic colorectal cancerBeale, Philip; Chua, Wei; Clarke, Stephen; Leung, Melissa; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: MedicineRetrospective review of mitomycin C use as third-line chemotherapy in metastatic colorectal cancer, Asia Pacific Journal of Clinical Oncology, vol.4,(3),2008,pp 132-136
2012Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancerCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Concord Clinical School: MedicineSystemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer, Supportive Care in Cancer, vol.20, 8, 2012,pp 1869-1874
2009Third-line Treatment Options for Metastatic Colorectal CancerBeale, Philip; Chua, Wei; Clarke, Stephen; Moore, Melissa; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Western Clinical School: Medicine (Westmead)Third-line Treatment Options for Metastatic Colorectal Cancer, Asia Pacific Journal of Oncology & Hematology, vol.1,(1),2009,pp 27-35
2011Use of inflammatory markers to guide cancer treatmentCharles (nee Slaviero), Kellie; Chua, Wei; Clarke, Stephen; Kao, S. C. H.; McMillan, D; Moore, M; Phan, V. H.; Tan, C; School of Medical Sciences: Pharmacology; Concord Clinical School: Medicine; Northern Clinical School: Kolling InstituteUse of inflammatory markers to guide cancer treatment, Clinical Pharmacology and Therapeutics, vol.90, 3, 2011,pp 475-478